{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:42:55Z","timestamp":1793662975415,"version":"4.5.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00392-020-01797-5","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T10:08:06Z","timestamp":1622110086000},"page":"163-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY)"],"prefix":"10.1007","volume":"111","author":[{"given":"Marion","family":"Hourqueig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bouzille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Mirabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Huttin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Labombarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Eicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"R\u00e9ant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Hag\u00e8ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2677-3389","authenticated-orcid":false,"given":"Erwan","family":"Donal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the REMY working group of the French Society of Cardiology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"1797_CR1","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","volume":"138","author":"CY Ho","year":"2018","unstructured":"Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Cirino AL, Fox JC, Lakdawala NK, Ware JS, Caleshu CA, Helms AS, Colan SD, Girolami F, Cecchi F, Seidman CE, Sajeev G, Signorovitch J, Green EM, Olivotto I, For the SHaRe Investigators (2018) Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe). Circulation 138:1387\u20131398","journal-title":"Circulation"},{"key":"1797_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. The Lancet 381:242\u2013255","journal-title":"The Lancet"},{"key":"1797_CR3","unstructured":"Hypertrophic obstructive cardiomyopathy\u2014The Lancet. https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(16)31321-6\/fulltext (10 April 2020)"},{"key":"1797_CR4","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/0735-1097(95)00353-3","volume":"26","author":"F Cecchi","year":"1995","unstructured":"Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ (1995) Hypertrophic cardiomyopathy in tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26:1529\u20131536","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR5","doi-asserted-by":"publisher","first-page":"e005820","DOI":"10.1161\/CIRCEP.117.005820","volume":"11","author":"BJ Maron","year":"2018","unstructured":"Maron BJ, Casey SA, Olivotto I, Sherrid MV, Semsarian C, Autore C, Ahmed A, Boriani G, Francia P, Winters SL, Giudici M, Koulova A, Garberich R, Rowin EJ, Sears SF, Maron MS, Spirito P (2018) Clinical course and quality of life in high-risk patients with hypertrophic cardiomyopathy and implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol 11:e005820","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1797_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","volume":"100","author":"OP Guttmann","year":"2014","unstructured":"Guttmann OP, Rahman MS, O\u2019Mahony C, Anastasakis A, Elliott PM (2014) Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart 100:465\u2013472","journal-title":"Heart"},{"key":"1797_CR7","doi-asserted-by":"crossref","unstructured":"Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104(21):2517\u20132524","DOI":"10.1161\/hc4601.097997"},{"key":"1797_CR8","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1253\/circj.CJ-09-0140","volume":"73","author":"T Kubo","year":"2009","unstructured":"Kubo T, Kitaoka H, Okawa M, Hirota T, Hayato K, Yamasaki N, Matsumura Y, Yabe T, Takata J, Doi YL (2009) Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy. Circ J 73:1599\u20131605","journal-title":"Circ J"},{"key":"1797_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.hjc.2017.01.027","volume":"58","author":"T Zegkos","year":"2017","unstructured":"Zegkos T, Efthimiadis GK, Parcharidou DG, Gossios TD, Giannakoulas G, Ntelios D, Ziakas A, Paraskevaidis S, Karvounis HI (2017) Atrial fibrillation in hypertrophic cardiomyopathy: a turning point towards increased morbidity and mortality. Hellenic J Cardiol 58:331\u2013339","journal-title":"Hellenic J Cardiol"},{"key":"1797_CR10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0735-1097(10)80014-2","volume":"15","author":"K Robinson","year":"1990","unstructured":"Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, Mckenna WJ (1990) Atrial fibrillation in hypertrophie cardiomyopathy: a longitudinal study. J Am Coll Cardiol 15:1279\u20131285","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR11","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"BJ Maron","year":"2003","unstructured":"Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED, Vogel RA, Abrams J, Bates ER, Brodie BR, Danias PG, Gregoratos G, Hlatky MA, Hochman JS, Kaul S, Lichtenberg RC, Lindner JR, O\u2019rourke RA, Pohost GM, Schofield RS, Tracy CM, Winters WL, Klein WW, Priori SG, Alonso-Garcia A et al (2003) American college of cardiology\/European society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 42:1687\u20131713","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ejhf.316","volume":"17","author":"OP Guttmann","year":"2015","unstructured":"Guttmann OP, Pavlou M, O\u2019Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM, for the Hypertrophic Cardiomyopathy Outcomes Investigators (2015) Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA): prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA). Eur J Heart Fail 17:837\u2013845","journal-title":"Eur J Heart Fail"},{"key":"1797_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","volume":"39","author":"BJ Maron","year":"2002","unstructured":"Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP, Casey SA, Gohman TE, Bongioanni S, Spirito P (2002) Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 39:301\u2013307","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR14","doi-asserted-by":"crossref","unstructured":"Raviele A, Bongiorni MG, Brignole M, Cappato R, Capucci A, Gaita F, Gulizia M, Mangiameli S, Montenero AS, Pedretti RF, Uriarte JA, Sermasi S,\nNisam S (2005) BEST + ICD Trial Investigators. Europace 7(4):327\u2013337","DOI":"10.1016\/j.eupc.2005.03.003"},{"key":"1797_CR15","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/0735-1097(89)90302-1","volume":"13","author":"F Cecchi","year":"1989","unstructured":"Cecchi F, Maron BJ, Epstein SE (1989) Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol 13:1283\u20131288","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/hrt.78.1.44","volume":"78","author":"F Cecchi","year":"1997","unstructured":"Cecchi F, Montereggi A, Olivotto I, Marconi P, Dolara A, Maron BJ (1997) Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration. Heart 78:44\u201349","journal-title":"Heart"},{"key":"1797_CR17","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1007\/s00380-019-01440-y","volume":"34","author":"Y Sugiura","year":"2019","unstructured":"Sugiura Y, Morimoto R, Aoki S, Yamaguchi S, Haga T, Kuwayama T, Yokoi T, Hiraiwa H, Kondo T, Watanabe N, Kano N, Fukaya K, Sawamura A, Okumura T, Murohara T (2019) Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death. Heart Vessels 34:2002\u20132010","journal-title":"Heart Vessels"},{"issue":"14","key":"1797_CR18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/0002-9149(92)90939-V","volume":"69","author":"PL Spirito","year":"1992","unstructured":"Spirito PL, Lakatos E, Maron BJ (1992) Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. Am J Cardiol 69(14):1217\u20131222","journal-title":"Am J Cardiol"},{"key":"1797_CR19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/heartjnl-2016-309672","volume":"103","author":"OP Guttmann","year":"2017","unstructured":"Guttmann OP, Pavlou M, O\u2019Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM (2017) Predictors of atrial fibrillation in hypertrophic cardiomyopathy. Heart 103:672\u2013678","journal-title":"Heart"},{"issue":"Suppl 1","key":"1797_CR20","first-page":"133","volume":"37","author":"Y Doi","year":"2001","unstructured":"Doi Y, Kitaoka H (2001) Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation.  J Cardiol 37(Suppl 1):133\u2013138","journal-title":"J Cardiol"},{"key":"1797_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijcard.2018.09.083","volume":"275","author":"M Mirabel","year":"2019","unstructured":"Mirabel M, Damy T, Donal E, Huttin O, Labombarda F, Eicher J-C, Cervino C, Laurito M, Offredo L, Tafflet M, Jouven X, Giura G, Desnos M, Jeunema\u00eetre X, Empana J-P, Charron P, Habib G, R\u00e9ant P, Hag\u00e8ge A (2019) Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: a study from the French register of hypertrophic cardiomyopathy (REMY). Int J Cardiol 275:107\u2013113","journal-title":"Int J Cardiol"},{"key":"1797_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/ehjci\/jev116","volume":"16","author":"P Lancellotti","year":"2015","unstructured":"Lancellotti P, Plon ska-Gosciniak E, Garbi M, Bucciarelli-ducci C, Cosyns B, Cardim N, Galderisi M, Edvardsen T, Neglia D, Plein S, Kitsiou A, Nieman K, Stefanidis A, Maurer G, Popescu BA, Habib G (2015) Cardiovascular imaging practice in Europe: a report from the European association of cardiovascular imaging. European Heart J-Cardiovasc Imaging 16:697\u2013702","journal-title":"European Heart J-Cardiovasc Imaging"},{"key":"1797_CR23","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jacc.2018.12.076","volume":"73","author":"J Sanz","year":"2019","unstructured":"Sanz J, S\u00e1nchez-Quintana D, Bossone E, Bogaard HJ, Naeije R (2019) Anatomy, function, and dysfunction of the right ventricle: JACC state-of-the-art review. J Am Coll Cardiol 73:1463\u20131482","journal-title":"J Am Coll Cardiol"},{"key":"1797_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2012","unstructured":"Stekhoven DJ, Buhlmann P (2012) MissForest\u2014non-parametric missing value imputation for mixed-type data. Bioinformatics 28:112\u2013118","journal-title":"Bioinformatics"},{"key":"1797_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.32614\/RJ-2015-026","volume":"7","author":"E Vigneau","year":"2015","unstructured":"Vigneau E, Chen M, Mostafa QE (2015) ClustVarLV: an R package for the clustering of variables around latent variables. The R Journal 7:134","journal-title":"The R Journal"},{"key":"1797_CR26","unstructured":"R Development Core Team (2010) A language and environment for statistical computing: reference index. Vienna: R Foundation for Statistical Computing."},{"key":"1797_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1177\/1474515118778445","volume":"17","author":"M Streur","year":"2018","unstructured":"Streur M, Ratcliffe SJ, Callans D, Shoemaker MB, Riegel B (2018) Atrial fibrillation symptom clusters and associated clinical characteristics and outcomes: a cross-sectional secondary data analysis. Eur J Cardiovasc Nurs 17:707\u2013716","journal-title":"Eur J Cardiovasc Nurs"},{"key":"1797_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11010-014-2324-8","volume":"402","author":"K Weber","year":"2015","unstructured":"Weber K, Rostert N, Bauersachs S, Wess G (2015) Serum microRNA profiles in cats with hypertrophic cardiomyopathy. Mol Cell Biochem 402:171\u2013180","journal-title":"Mol Cell Biochem"},{"key":"1797_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/ehjci\/jey097","volume":"20","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi Y, Moneghetti KJ, Bouajila S, Stolfo D, Finocchiaro G, Kuznetsova T, Liang D, Schnittger I, Ashley E, Wheeler M, Haddad F (2019) Time based versus strain based myocardial performance indices in hypertrophic cardiomyopathy, the merging role of left atrial strain. Eur Heart J Cardiovasc Imaging Oxford Academic 20:334\u2013342","journal-title":"Eur Heart J Cardiovasc Imaging Oxford Academic"},{"key":"1797_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrcardio.2016.45","volume":"13","author":"D Ko","year":"2016","unstructured":"Ko D, Rahman F, Schnabel RB, Yin X, Benjamin EJ, Christophersen IE (2016) Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol 13:321\u2013332","journal-title":"Nat Rev Cardiol"},{"key":"1797_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","volume":"386","author":"RB Schnabel","year":"2015","unstructured":"Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D (2015) 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study. Lancet 386:154\u2013162","journal-title":"Lancet"},{"key":"1797_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/jamacardio.2019.4534","volume":"5","author":"M Lorenzini","year":"2020","unstructured":"Lorenzini M, Anastasiou Z, O\u2019Mahony C, Guttman OP, Gimeno JR, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Garcia-Pavia P, Limongelli G, Pavlou M, Elliott PM (2020) Mortality among referral patients with hypertrophic cardiomyopathy vs the general European population. JAMA Cardiol 5:73\u201380","journal-title":"JAMA Cardiol"},{"key":"1797_CR33","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.4022\/jafib.1556","volume":"10","author":"A Ali","year":"2018","unstructured":"Ali A (2018) Atrial fibrillation in hypertrophic cardiomyopathy: diagnosis and considerations for management. J Atrial Fibrillation 10:1556","journal-title":"J Atrial Fibrillation"},{"key":"1797_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1160\/TH16-11-0825","volume":"117","author":"V Allan","year":"2017","unstructured":"Allan V, Honarbakhsh S, Casas J-P, Wallace J, Hunter R, Schilling R, Perel P, Morley K, Banerjee A, Hemingway H (2017) Are cardiovascular risk factors also associated with the incidence of atrial fibrillation?: a systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thromb Haemost 117:837\u2013850","journal-title":"Thromb Haemost"},{"key":"1797_CR35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/ajh\/hpx013","volume":"30","author":"MS Dzeshka","year":"2017","unstructured":"Dzeshka MS, Shahid F, Shantsila A, Lip GYH (2017) Hypertension and atrial fibrillation: an intimate association of epidemiology, pathophysiology, and Outcomes. Am J Hypertens 30:733\u2013755","journal-title":"Am J Hypertens"},{"key":"1797_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.phrs.2017.10.007","volume":"128","author":"MS Kallistratos","year":"2018","unstructured":"Kallistratos MS, Poulimenos LE, Manolis AJ (2018) Atrial fibrillation and arterial hypertension. Pharmacol Res 128:322\u2013326","journal-title":"Pharmacol Res"},{"key":"1797_CR37","unstructured":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis\u2014The Lancet Neurology. https:\/\/www.thelancet.com\/journals\/laneur\/article\/PIIS1474-4422(15)70027-X\/fulltext (1 April 2020)"},{"key":"1797_CR38","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.12.045","volume":"113","author":"BJ Maron","year":"2014","unstructured":"Maron BJ, Haas TS, Maron MS, Lesser JR, Browning JA, Chan RH, Olivotto I, Garberich RF, Schwartz RS (2014) Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance. The Am J Cardiol 113:1394\u20131400","journal-title":"The Am J Cardiol"},{"key":"1797_CR39","doi-asserted-by":"crossref","unstructured":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733\u20132779.","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"1797_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/ehjci\/jev354","volume":"17","author":"E Donal","year":"2016","unstructured":"Donal E, Lip GYH, Galderisi M, Goette A, Shah D, Marwan M, Lederlin M, Mondillo S, Edvardsen T, Sitges M, Grapsa J, Garbi M, Senior R, Gimelli A, Potpara TS, Van Gelder IC, Gorenek B, Mabo P, Lancellotti P, Kuck K-H, Popescu BA, Hindricks G, Habib G, Cosyns B, Delgado V, Haugaa KH, Muraru D, Nieman K, Cohen A (2016) EACVI\/EHRA Expert consensus document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging 17:355\u2013383","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"11","key":"1797_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/jcm7110447","volume":"7","author":"JR Smith","year":"2018","unstructured":"Smith JR, Medina-Inojosa JR, Layrisse V, Ommen SR, Olson TP (2018) Predictors of exercise capacity in patients with hypertrophic obstructive cardiomyopathy. J Clin Med 7(11):447","journal-title":"J Clin Med"},{"key":"1797_CR42","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1378\/chest.128.5.3428","volume":"128","author":"J-W Ha","year":"2005","unstructured":"Ha J-W, Cho J-R, Kim J-M, Ahn J-A, Choi E-Y, Kang S-M, Rim S-J, Chung N (2005) Tissue doppler-derived indices predict exercise capacity in patients with apical hypertrophic cardiomyopathy. Chest 128:3428\u20133433","journal-title":"Chest"},{"key":"1797_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.echo.2007.05.027","volume":"21","author":"CSP Lam","year":"2008","unstructured":"Lam CSP, Han L, Oh JK, Yang H, Ling LH (2008) The mitral annular middiastolic velocity curve: functional correlates and clinical significance in patients with left ventricular hypertrophy. J Am Soc Echocardiogr 21:165\u2013170","journal-title":"J Am Soc Echocardiogr"},{"key":"1797_CR44","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/eurheartj\/ehr378","volume":"33","author":"MA Rosenberg","year":"2012","unstructured":"Rosenberg MA, Gottdiener JS, Heckbert SR, Mukamal KJ (2012) Echocardiographic diastolic parameters and risk of atrial fibrillation: the cardiovascular health study. Eur Heart J 33:904\u2013912","journal-title":"Eur Heart J"},{"key":"1797_CR45","unstructured":"The mitral valve in hypertrophic cardiomyopathy: old versus new concepts. PubMed-NCBI. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21909825 (1 April 2020)"},{"key":"1797_CR46","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.amjcard.2019.05.021","volume":"124","author":"YL Hiemstra","year":"2019","unstructured":"Hiemstra YL, Debonnaire P, Bootsma M, Schalij MJ, Bax JJ, Delgado V, Marsan NA (2019) Prevalence and prognostic implications of right ventricular dysfunction in patients with hypertrophic cardiomyopathy. The Am J Cardiol 124:604\u2013612","journal-title":"The Am J Cardiol"},{"key":"1797_CR47","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/ehjci\/jew024","volume":"17","author":"KC Ong","year":"2016","unstructured":"Ong KC, Geske JB, Hebl VB, Nishimura RA, Schaff HV, Ackerman MJ, Klarich KW, Siontis KC, Coutinho T, Dearani JA, Ommen SR, Gersh BJ (2016) Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 17:604\u2013610","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1797_CR48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijcard.2017.07.010","volume":"248","author":"MB Musumeci","year":"2017","unstructured":"Musumeci MB, Mastromarino V, Casenghi M, Tini G, Francia P, Maruotti A, Romaniello A, Magr\u00ec D, Lillo R, Adduci C, Volpe M, Autore C (2017) Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy. Int J Cardiol 248:326\u2013332","journal-title":"Int J Cardiol"},{"key":"1797_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00399-020-00668-w","volume":"31","author":"D Bandorski","year":"2020","unstructured":"Bandorski D, Bogossian H, Ghofrani A, Schmitt J, H\u00f6ltgen R (2020) Tachykardien bei pulmonalarterieller Hypertonie. Herzschr Elektrophys 31:33\u201338","journal-title":"Herzschr Elektrophys"},{"key":"1797_CR50","unstructured":"The SHaRe cardiomyopathy registry | From care to cure. https:\/\/theshareregistry.org\/home\/patient (26 March 2020)"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-020-01797-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-020-01797-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-020-01797-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T05:14:45Z","timestamp":1650258885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-020-01797-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1007\/s00392-020-01797-5","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"assertion":[{"value":"3 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The copyright year for this article was incorrectly given as 2020 but should have been 2021.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}